Pharmaceutical Technology

JUNE 18, 2025

By GlobalData Learn more about Strategic Intelligence FDA’s strategy on trial designs, vaccines and manufacturing Earlier this month, when the Department of Health and Human Sciences Secretary Robert Kennedy Jr.

FDA

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock.

FDA

Pharmaceutical Technology

JULY 23, 2025

July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition includes vaccine candidates for respiratory syncytial virus and human metapneumovirus. The technology stabilises viral proteins in their native shape, which may lead to more effective immune responses. Credit: Kitsawet Saethao/Shutterstock.com.

Health and Personal Care Stores

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Uncertainty looms over FDA scheme to boost US manufacturing The FDA’s new PreCheck programme is aimed at facilitating the introduction of new US drug manufacturing facilities.

FDA

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Epkinly breaks ground in Phase III FL trial While Epkinly is approved in third-line follicle lymphoma, its success in the second-line setting is pertinent.

Packaging

Pharmaceutical Technology

JUNE 20, 2025

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Data Insights The gold standard of business intelligence. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Hospitals

Pharmaceutical Technology

JULY 3, 2025

How will RFK Jr’s American dream for vaccines play out? It comes with one for cytokine release syndrome (CRS) and neurologic toxicity – including immune effector cell-associated neurotoxicity syndrome – in addition to warnings and precautions for infections, neutropenia, hepatotoxicity and embryo-foetal toxicity.

FDA

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. Investors shared positive sentiment in the acquisition, with shares in NYSE-listed AbbVie closing 1.7%

Packaging

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock.

Labelling

Pharmaceutical Technology

AUGUST 5, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Immunization

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News CorMedix signs agreement to acquire Melinta for $300m The acquisition entails royalties from US net sales of both Rezzayo and Minocin.

Packaging

Pharmaceutical Technology

JUNE 11, 2025

CD4+T-cells and lymphocytes are both crucial elements of the immune system. The FDA placed a hold on the trials due to the identification of a safety signal of decreases in CD4+T-cell (CD4) and absolute lymphocyte counts in a subset of participants receiving the GS-1720 and GS-4182 combination.

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. Sino revealed the acquisition agreement after trading hours on 15 July. The share price in the company had climbed 3.6% by market close.

Packaging

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? Its design minimises interaction with Fc-gamma (Fcγ) receptors on macrophages, enhancing the ability of the body’s immune cells to recognise and combat tumours.

Packaging

Pharmaceutical Technology

JUNE 16, 2025

Keytruda is designed to enhance the immune system’s ability to detect and combat tumour cells. Based on these trial results, Keytruda as part of this regimen shows potential to change long-standing standards of care for treating certain patients with locally advanced HNSCC.”

FDA

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Astria Therapeutics licenses navenibart rights to Kaken for HAE Astria will receive $16m upfront and is eligible for a further $16m in commercialisation and sales milestones. Sign up for our daily news round-up!

Packaging

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien.

Hospitals

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? LEO’s new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor – a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases.

Packaging

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Mounjaro and Zepbound fuel strong Q2 growth for Eli Lilly Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.

Packaging

Pharmaceutical Technology

AUGUST 6, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Fresenius Kabi signs global licensing deal for Polpharma’s vedolizumab biosimilar Vedolizumab is a biologic therapy indicated for treatment of ulcerative colitis and Crohn’s disease.

Packaging

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines

Pharmaceutical Technology

AUGUST 6, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Novo Nordisk files 14 new lawsuits against unapproved semaglutide drugs The company has so far filed 132 complaints in federal courts across 40 US states.

Compounding

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News FDA removes Ixchiq partial pause but tightens vaccine’s use The FDA completed a benefit-risk revaluation following two deaths in the French territory of La Réunion. Shares in Paris-listed Valneva opened 11% higher on 8 August at €3.63.

FDA

Pharmaceutical Technology

AUGUST 6, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Novo Nordisk’s diabetes and weight loss drug sales growth decelerates H1 sales growth for Novo’s segment that includes Ozempic and Wegovy was down from the same period in 2024.

Compounding

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News RFK Jr’s mRNA funding halt signals “shift in US public health” The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes. Image credit: Jim Watson, AFP via Getty Images.

Vaccines

Pharmaceutical Technology

JUNE 25, 2025

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Go deeper with GlobalData Reports ESG (Environmental, Social, and Governance) in Healthcare - Themati.

Vaccines

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. Data Insights The gold standard of business intelligence.

Vaccines

Pharmaceutical Technology

AUGUST 8, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT In Association with MarketScan Partner Content Podcast: Why the healthcare industry needs linked data Linked data could unlock essential hidden insights across healthcare – but linking has to be executed correctly to avoid common pitfalls.

Patient Care

Pharmaceutical Technology

JUNE 25, 2025

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration. Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US.

Vaccines

Pharmaceutical Technology

JUNE 16, 2025

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Two patients experienced dose-limiting toxicities and continued to receive the targeted dose.

Labelling

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Why Liverpool’s Wirtz is causing concern at big pharma company Bayer Bayer disclosed that its Q2 earnings were inflated by transfer fees at its German football club Bayer Leverkusen.

Packaging

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The mRNA vaccine candidates will help reduce the chances of autoimmune responses that might lead to allergic conditions or serious autoimmune diseases.

Vaccines

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Pharmaceutical Technology

MARCH 24, 2023

Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.

Vaccines

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines

Pharmaceutical Technology

JUNE 12, 2025

US Health Secretary Robert F Kennedy (RFK) Jr has appointed eight new members to the vaccine advisory panel at the Centers for Disease Control and Prevention (CDC), just days after firing the panel’s previous members in full. Credit: LightRocket via Getty Images. Credit: LightRocket via Getty Images. Who’s on the panel?

Vaccines

Pharmaceutical Technology

DECEMBER 1, 2022

A clinical-stage biopharmaceutical firm, Liminatus focuses on the development of new therapies for cancer that utilises the immune system of the body to detect and fight cancer cells. The GCC Vaccine is being analysed in Phase II clinical trials. The boards of directors of both companies have granted approval for the merger.

Immunization